for Veterans and the Public
Emtriva (emtricitabine, FTC)
- Type of Drug: Nucleoside Reverse Transcriptase Inhibitor
Nucleoside reverse transcriptase inhibitors were the first type of drug available to treat HIV. They are also known as NRTIs, nucleoside analogues, or "nukes."
When the HIV virus enters a healthy cell, it attempts to make copies of itself. It does this by using an enzyme called reverse transcriptase. NRTIs block that enzyme, so HIV cannot make new copies of itself.
Bring a printout of this page to discuss with your doctor during your next visit. List your questions at the bottom of the page.
Approved adult dosing
one 200 mg capsule Emtriva once a day
Notes on taking this medication
- No food restrictions, can take with or without food
- Persons with kidney problems may need an adjustment to their dose of emtricitabine
- Do not take emtricitabine with lamivudine
- Skin discoloration (particularly in dark-skinned people)
- Emtricitabine (Emtriva) is active against hepatitis B, and stopping it can cause "flare-up" of hepatitis B
See accompanying chart: Tips for Common Side Effects
Disclaimer: This information is not meant to substitute for advice from your medical provider or pharmacist. If you have any questions about your medication dosing, talk to your medical provider or pharmacist.